Nina Capital
Also known as Nina Capital SGEIC, S.A., nina.capital
Barcelona health-tech VC manager founded 2019 by Marta G. Zanchi; three funds (€18M, >€40M, €50M), €200K–€1.5M tickets at pre-seed and seed in Europe, US, Israel and Canada.
- HEADQUARTERS
- Barcelona, Spain
- FOUNDED
- 2019
- AUM
- €100M (2025)
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 6 people
FOCUS
- STAGES
- Pre-SeedSeedSeries A
- ASSET MIX
- Venture capital
- GEOGRAPHY
- EuropeUnited StatesIsraelCanada
WHAT IT IS
VC Fund. A fund manager investing capital raised from limited partners into startups.
ABOUT
Nina Capital SGEIC, S.A. is a CNMV-registered manager (no. 148, July 2019) in Barcelona, founded in 2019 by Dr. Marta G. Zanchi. It invests only at the intersection of healthcare and technology — healthcare tools and medical devices, not drugs or vaccines — leading or co-investing €200K–€1.5M from pre-seed to seed+. Its funds are an €18M 2019 vintage, a second fund that passed its €40M target in 2022, and the €50M Fund III launched in 2025, taking AUM over €100M; the website reports 58 companies invested across its funds.
INVESTMENT THESIS
Healthcare transformation powered by information technology and led by need-driven founders: healthcare tools for providers and payers and medical devices, excluding drugs and vaccines. Pre-seed to seed+, €200K–€1.5M, lead or co-invest, in Europe, the US, Israel, Canada and Australia.
PORTFOLIO (12)
- ContextflowNOTABLEArtificial Intelligence
- UltromicsNOTABLEArtificial Intelligence
- LeukoHealthTech
- TeiaCareHealthTech
- EarlySightHealthTech
- MedAllEducation
- Sonar Mental HealthHealthTech
- Subtle MedicalArtificial Intelligence
- MindpeakArtificial Intelligence
- QuantHealthArtificial Intelligence
- CardiomaticsHealthTech
- LillianCareHealthTech
TEAM
LINKS
FAQ
Nina Capital is a VC fund based in Barcelona, Spain, founded in 2019.
Yes. Nina Capital invests directly in private companies.
Nina Capital invests at Pre-Seed, Seed and Series A stages in HealthTech, Artificial Intelligence and Software & SaaS.
Nina Capital's stated ticket size is €200K–€1.5M.
Key people at Nina Capital include Marta G. Zanchi (Founder & Managing Partner), Marc Subirats (General Partner), Sebastian Anastassiou (Partner) and Yahel Halamish (Partner).
Nina Capital's investments include Contextflow, Ultromics, Leuko, TeiaCare, EarlySight, MedAll, Sonar Mental Health and Subtle Medical, among others.
Nina Capital states that it accepts submissions through its official contact page.
Yes. Nina Capital manages capital from outside investors.